| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| 03/31/2021 |
Director
Trans History: 207
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 420 | $46.50 | 47,847 |
| 03/31/2021 |
President
Trans History: 218
|
President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 24 | $36.62 | 69,983 |
| 03/31/2021 |
Director
Trans History: 96
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 453 | $46.50 | 36,829 |
| 03/23/2021 |
Senior Vice President
Trans History: 119
|
Senior Vice President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12 | $48.93 | 271 |
| 03/23/2021 |
Director, Chief Executive Officer
Trans History: 321
|
Director, Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30 | $48.93 | 2,440 |
| 03/18/2021 |
Director
Trans History: 177
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | $9.02 | 43,789 |
| 03/18/2021 |
Director
Trans History: 177
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | $12.46 | 45,289 |
| 03/18/2021 |
Director
Trans History: 177
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 3,000 | $48.38 | 42,289 |
| 03/18/2021 |
Director
Trans History: 177
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | -- | -- |
| 03/18/2021 |
Director
Trans History: 177
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | -- | -- |
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.